CorMedix Inc.

3.45-0.1700-4.70%Vol 4.21M1Y Perf -53.89%
Jun 24th, 2022 16:00 DELAYED
BID3.30 ASK3.47
Open3.63 Previous Close3.62
Pre-Market- After-Market3.55
 - -  0.10 2.90%
Target Price
27.00 
Analyst Rating
Strong Buy 1.00
Potential %
682.61 
Finscreener Ranking
★★★★★     60.92
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
★★★★     55.04
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
★★★+     53.78
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
14.68 
Earnings Rating
Strong Buy
Market Cap134.97M 
Earnings Date
11th Aug 2022
Alpha0.02 Standard Deviation0.32
Beta2.41 

Today's Price Range

3.303.79

52W Range

2.658.13

5 Year PE Ratio Range

-5.70-3.90

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Sell
Performance
1 Week
22.34%
1 Month
6.48%
3 Months
-43.07%
6 Months
-30.72%
1 Year
-53.89%
3 Years
-55.25%
5 Years
53.33%
10 Years
187.50%

TickerPriceChg.Chg.%
CRMD3.45-0.1700-4.70
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
14.40
14.60
0.01
0.01
-1 813.30
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
19.20
-26 526.40
-26 462.80
-9 807.40
-
RevenueValueIndustryS&P 500US Markets
110.31K
0.00
-29.18
-9.90
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.23-0.1821.74
Q04 2021-0.22-0.209.09
Q03 2021-0.18-0.22-22.22
Q02 2021-0.18-0.1233.33
Q01 2021-0.18-0.20-11.11
Q04 2020-0.23-0.1917.39
Q03 2020-0.26-0.2215.38
Q02 2020-0.24-0.1441.67
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.2020.00Positive
9/2022 QR-0.250.00-
12/2022 FY-0.840.00-
12/2023 FY-0.63--
Next Report Date11th Aug 2022
Estimated EPS Next Report-0.20
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume4.21M
Shares Outstanding39.12K
Shares Float38.74M
Trades Count6.76K
Dollar Volume14.60M
Avg. Volume396.52K
Avg. Weekly Volume423.60K
Avg. Monthly Volume396.57K
Avg. Quarterly Volume369.39K

CorMedix Inc. (AMEX: CRMD) stock closed at 3.45 per share at the end of the most recent trading day (a -4.7% change compared to the prior day closing price) with a volume of 4.21M shares and market capitalization of 134.97M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 30 people. CorMedix Inc. CEO is Khoso Baluch.

The one-year performance of CorMedix Inc. stock is -53.89%, while year-to-date (YTD) performance is -24.18%. CRMD stock has a five-year performance of 53.33%. Its 52-week range is between 2.645 and 8.13, which gives CRMD stock a 52-week price range ratio of 14.68%

CorMedix Inc. currently has a PE ratio of -3.90, a price-to-book (PB) ratio of 1.84, a price-to-sale (PS) ratio of 1 000.14, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -37.57%, a ROC of -39.46% and a ROE of -39.99%. The company’s profit margin is -%, its EBITDA margin is -26 462.80%, and its revenue ttm is $110.31 Thousand , which makes it $0.00 revenue per share.

Of the last four earnings reports from CorMedix Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.20 for the next earnings report. CorMedix Inc.’s next earnings report date is 11th Aug 2022.

The consensus rating of Wall Street analysts for CorMedix Inc. is Strong Buy (1), with a target price of $27, which is +682.61% compared to the current price. The earnings rating for CorMedix Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CorMedix Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

CorMedix Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 29.26, ATR14 : 0.28, CCI20 : 187.33, Chaikin Money Flow : -0.10, MACD : -0.06, Money Flow Index : 79.10, ROC : 13.11, RSI : 55.87, STOCH (14,3) : 70.31, STOCH RSI : 0.81, UO : 58.25, Williams %R : -29.69), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CorMedix Inc. in the last 12-months were: Joseph Todisco (Buy at a value of $33 800), Matthew David (Buy at a value of $5 070), Matthew T. David (Buy at a value of $5 070), Myron Kaplan (Buy at a value of $70 300)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

CorMedix Inc.

Cormedix Inc is a biopharmaceutical company which focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution or the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as dialysis, critical/intensive care, and oncology. The Neutrolin product is designed to target unmet medical need.

CEO: Khoso Baluch

Telephone: +1 908 517-9500

Address: 400 Connell Drive, Berkeley Heights 07922, NJ, US

Number of employees: 30

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

75%25%

Bearish Bullish

56%44%

Bearish Bullish

52%48%

TipRanks News for CRMD

Fri, 13 May 2022 10:45 GMT Analysts Are Bullish on Top Healthcare Stocks: Cormedix (CRMD), Achieve Life Sciences (ACHV)

- TipRanks. All rights reserved.

Fri, 13 May 2022 04:15 GMT Analysts Are Bullish on Top Healthcare Stocks: Cormedix (CRMD), SI-Bone (SIBN)

- TipRanks. All rights reserved.

Wed, 30 Mar 2022 10:19 GMT Analysts Are Bullish on Top Healthcare Stocks: Cormedix (CRMD), Infinity Pharma (INFI)

- TipRanks. All rights reserved.

Wed, 30 Mar 2022 04:15 GMT Analysts Are Bullish on Top Healthcare Stocks: Cormedix (CRMD), Enanta Pharmaceuticals (ENTA)

- TipRanks. All rights reserved.

Fri, 18 Mar 2022 04:15 GMT Cormedix (CRMD) Received its Third Buy in a Row

- TipRanks. All rights reserved.

News

Stocktwits